Literature DB >> 23917464

Heart failure: Heart failure clinical trials: how do we define success?

Boback Ziaeian1, Gregg C Fonarow.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23917464      PMCID： PMC4315498          DOI： 10.1038/nrcardio.2013.115

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Rehospitalizations among patients in the Medicare fee-for-service program.

Authors:  Stephen F Jencks; Mark V Williams; Eric A Coleman
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

2.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

3.  Viewpoint: Central adjudication of myocardial infarction in outcome-driven clinical trials--common patterns in TRITON, RECORD, and PLATO?

Authors:  Victor L Serebruany; Dan Atar
Journal:  Thromb Haemost       Date:  2012-07-26       Impact factor: 5.249

4.  Composite outcomes in cardiovascular research: a survey of randomized trials.

Authors:  Eric Lim; Adam Brown; Adel Helmy; Shafi Mussa; Douglas G Altman
Journal:  Ann Intern Med       Date:  2008-11-04       Impact factor: 25.391

Review 5.  The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention.

Authors:  Kevin E Kip; Kim Hollabaugh; Oscar C Marroquin; David O Williams
Journal:  J Am Coll Cardiol       Date:  2008-02-19       Impact factor: 24.094

6.  Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.

Authors:  Anju Bhardwaj; Shafiq U Rehman; Asim A Mohammed; Hanna K Gaggin; Linda Barajas; Justine Barajas; Stephanie A Moore; Dorothy Sullivan; James L Januzzi
Journal:  Am Heart J       Date:  2012-11       Impact factor: 4.749

7.  Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.

Authors:  Faiez Zannad; Angeles Alonso Garcia; Stefan D Anker; Paul W Armstrong; Gonzalo Calvo; John G F Cleland; Jay N Cohn; Kenneth Dickstein; Michael J Domanski; Inger Ekman; Gerasimos S Filippatos; Mihai Gheorghiade; Adrian F Hernandez; Tiny Jaarsma; Joerg Koglin; Marvin Konstam; Stuart Kupfer; Aldo P Maggioni; Alexandre Mebazaa; Marco Metra; Christina Nowack; Burkert Pieske; Ileana L Piña; Stuart J Pocock; Piotr Ponikowski; Giuseppe Rosano; Luis M Ruilope; Frank Ruschitzka; Thomas Severin; Scott Solomon; Kenneth Stein; Norman L Stockbridge; Wendy Gattis Stough; Karl Swedberg; Luigi Tavazzi; Adriaan A Voors; Scott M Wasserman; Holger Woehrle; Andrew Zalewski; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2013-06-19       Impact factor: 15.534

8.  Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras.

Authors:  Richard M Cubbon; Christopher P Gale; Lorraine C Kearney; Clyde B Schechter; W Paul Brooksby; Jim Nolan; Keith A A Fox; Adil Rajwani; Wazir Baig; David Groves; Pauline Barlow; Anthony C Fisher; Phillip D Batin; Matthew B Kahn; Azfar G Zaman; Ajay M Shah; Jon A Byrne; Steven J Lindsay; Robert J Sapsford; Stephen B Wheatcroft; Klaus K Witte; Mark T Kearney
Journal:  Circ Heart Fail       Date:  2011-05-11       Impact factor: 8.790

9.  Systematic adjudication of myocardial infarction end-points in an international clinical trial.

Authors:  Kenneth W Mahaffey; Robert A Harrington; Martijn Akkerhuis; Neal S Kleiman; Lisa G Berdan; Brian S Crenshaw; Barbara E Tardiff; Christopher B Granger; Ingrid DeJong; Manju Bhapkar; Petr Widimsky; Ramón Corbalon; Kerry L Lee; Jaap W Deckers; Maarten L Simoons; Eric J Topol; Robert M Califf
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001-07-17

Review 10.  Challenges in coding adverse events in clinical trials: a systematic review.

Authors:  Jeppe Bennekou Schroll; Emma Maund; Peter C Gøtzsche
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240
  10 in total
  1 in total

Review 1.  Drugs' development in acute heart failure: what went wrong?

Authors:  Vincenzo Teneggi; Nithy Sivakumar; Deborah Chen; Alex Matter
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.